Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 38
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/5/2007
1.
Phase I-II Chemotherapy with Aclacinomycin-A for Advanced Colorectal Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
over 18
MDA-DT-8125
NCI-W81-0420
Last Modified:
7/1/1997
2.
Phase I-II Chemotherapy with Oral Aclacinomycin for Refractory Cancer of Breast, Ovary, Testis, and Lung, and Malignant Lymphoma (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
no age specified
NCI-81-C-116
NCI-MB-162
3.
Phase II Pilot Chemotherapy with Aclacinomycin in Patients with Advanced Ovarian Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D81-039-464
4.
Phase II Chemotherapy with Aclacinomycin with or without Adriamycin for Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
UMCT-1280
5.
Phase II Chemotherapy with Aclacinomycin-A for Renal Cell Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
WSU-C-40981
6.
Phase II Chemotherapy with Aclacinomycin-A for Squamous Cell Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
WSU-C-41081
7.
Phase II Combination Chemotherapy with ACM-A/VP-16 in Patients with Refractory ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
URCC-2482M
NCI-T83-0984D, T83-0984
8.
Phase II Chemotherapy with Aclacinomycin-A for Advanced, Measurable Gastric Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D81-039-204
9.
Phase II Chemotherapy with Weekly Aclacinomycin for Stage III/IV Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
SEG-BRE-81209
10.
Phase II Chemotherapy with Aclacinomycin Every 3 Weeks for Metastatic Breast Carcinoma Previously Treated with Nonanthracycline Agents
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
SEG-BRE-81210
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
